640 related articles for article (PubMed ID: 15809483)
21. Estimation of patient dose in (18)F-FDG and (18)F-FDOPA PET/CT examinations.
Kaushik A; Jaimini A; Tripathi M; D'Souza M; Sharma R; Mishra AK; Mondal A; Dwarakanath BS
J Cancer Res Ther; 2013; 9(3):477-83. PubMed ID: 24125986
[TBL] [Abstract][Full Text] [Related]
22. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
23. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
24. Giant cell arteritis on 18F-FDG PET/CT.
Heston TF; Szabo Z
Clin Physiol Funct Imaging; 2009 Sep; 29(5):382-4. PubMed ID: 19522856
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
[TBL] [Abstract][Full Text] [Related]
26. National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011.
Etard C; Celier D; Roch P; Aubert B
Radiat Prot Dosimetry; 2012 Dec; 152(4):334-8. PubMed ID: 22586156
[TBL] [Abstract][Full Text] [Related]
27. Whole-body 18F-FDG PET/CT in the presence of truncation artifacts.
Beyer T; Bockisch A; Kühl H; Martinez MJ
J Nucl Med; 2006 Jan; 47(1):91-9. PubMed ID: 16391192
[TBL] [Abstract][Full Text] [Related]
28. Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases.
D'souza MM; Sharma R; Mondal A; Jaimini A; Tripathi M; Saw SK; Singh D; Mishra A; Tripathi RP
Nucl Med Commun; 2009 Feb; 30(2):117-25. PubMed ID: 19057427
[TBL] [Abstract][Full Text] [Related]
29. PET and PET/CT in pediatric oncology.
Jadvar H; Connolly LP; Fahey FH; Shulkin BL
Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239
[TBL] [Abstract][Full Text] [Related]
30. Radiation exposure in body computed tomography examinations of trauma patients.
Kortesniemi M; Kiljunen T; Kangasmäki A
Phys Med Biol; 2006 Jun; 51(12):3269-82. PubMed ID: 16757876
[TBL] [Abstract][Full Text] [Related]
31. Patient radiation doses from adult and pediatric CT.
Huda W; Vance A
AJR Am J Roentgenol; 2007 Feb; 188(2):540-6. PubMed ID: 17242266
[TBL] [Abstract][Full Text] [Related]
32. Automated 3-dimensional elastic registration of whole-body PET and CT from separate or combined scanners.
Shekhar R; Walimbe V; Raja S; Zagrodsky V; Kanvinde M; Wu G; Bybel B
J Nucl Med; 2005 Sep; 46(9):1488-96. PubMed ID: 16157532
[TBL] [Abstract][Full Text] [Related]
33. Fever of unknown origin: the role of 18F-FDG PET/CT.
Keidar Z; Gurman-Balbir A; Gaitini D; Israel O
J Nucl Med; 2008 Dec; 49(12):1980-5. PubMed ID: 18997040
[TBL] [Abstract][Full Text] [Related]
34. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
[TBL] [Abstract][Full Text] [Related]
35. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ
Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887
[TBL] [Abstract][Full Text] [Related]
36. The determination of patient dose from (18)F-FDG PET/CT examination.
Khamwan K; Krisanachinda A; Pasawang P
Radiat Prot Dosimetry; 2010 Sep; 141(1):50-5. PubMed ID: 20400773
[TBL] [Abstract][Full Text] [Related]
37. Deriving staff and public doses in a PET/CT facility from measured radiation levels using thermoluminescent dosimetry.
Al-Haj AN; Lobriguito AM; Arafah A; Parker R
Radiat Prot Dosimetry; 2011 Mar; 144(1-4):487-91. PubMed ID: 21147788
[TBL] [Abstract][Full Text] [Related]
38. Radiation exposure of patients undergoing whole-body FDG-PET/CT examinations: an update pursuant to the new ICRP recommendations.
Brix G; Nosske D; Lechel U
Nuklearmedizin; 2014; 53(5):217-20. PubMed ID: 24919708
[TBL] [Abstract][Full Text] [Related]
39. A positron emission tomography/computed tomography (PET/CT) acquisition protocol for CT radiation dose optimization.
Wu TH; Chu TC; Huang YH; Chen LK; Mok SP; Lee JK; Yeu-Sheng T; Lee JJ
Nucl Med Commun; 2005 Apr; 26(4):323-30. PubMed ID: 15753791
[TBL] [Abstract][Full Text] [Related]
40. 18F protection issues: human and gamma-camera considerations.
Cao Z; Corley JH; Allison J
J Nucl Med Technol; 2003 Dec; 31(4):210-5. PubMed ID: 14657287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
